Ali Behbahani
Director at SpyGlass Pharma · 39 reported transactions in 7 companies · latest trade Sep 17, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −13.4%, S&P 500 +9.2% over the same days.
Their trades
Sold | Sep 17, 2026 | Sep 17, 2026 close $57.33 → Oct 29, 2026 close $54.26. S&P 500 +0.9% over the same days. | ||
Bought | Feb 9, 2026 | Feb 9, 2026 close $26.18 → Oct 28, 2026 close $32.86. S&P 500 +11.3% over the same days. |
$780.9K
Sep 17, 2026 close $57.33 → Oct 29, 2026 close $54.26. S&P 500 +0.9% over the same days.
BoughtSpyGlass Pharma
$15M
Feb 9, 2026 close $26.18 → Oct 28, 2026 close $32.86. S&P 500 +11.3% over the same days.